SI-BONE to Present at the Canaccord Genuity Musculoskeletal Conference
February 28 2019 - 3:05PM
SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that
is pioneering the minimally invasive surgical treatment of the
sacroiliac joint with the iFuse Implant System®, today announced
the company will be participating in the upcoming Canaccord Genuity
Musculoskeletal Conference in Las Vegas, Nevada.
SI-BONE’s management is scheduled to present on Tuesday, March
12, 2019 at 2:30 p.m. Pacific Time. Interested parties may access a
live and archived webcast of the presentation on the “Investors”
section of the company’s website at: www.si-bone.com.
About SI-BONESI-BONE is a medical device
company that pioneered the iFuse Implant System, a minimally
invasive surgical system for fusion of the sacroiliac joint to
treat sacroiliac joint dysfunction. The SI joint is believed
to be the last major joint with a clinically proven surgical
treatment. The iFuse Implant, commercially available since
2009, is believed to be the only SI joint fusion device supported
by multiple prospective clinical studies showing improved pain,
patient function and quality of life resulting from
treatment. There are over 60 peer-reviewed publications
supporting the safety, effectiveness, and biomechanical and
economic benefits unique to the iFuse Implant. This body of
evidence has enabled multiple government and private payers to
establish coverage of the SI joint fusion procedure exclusively
when performed with the iFuse Implant System.
The iFuse Implant System is intended for sacroiliac fusion for
conditions including sacroiliac joint dysfunction that is a direct
result of sacroiliac joint disruption and degenerative
sacroiliitis. This includes conditions whose symptoms began
during pregnancy or in the peripartum period and have persisted
postpartum for more than 6 months. There are potential risks
associated with the iFuse Implant System. It may not be
appropriate for all patients and all patients may not benefit.
SOURCE SI-BONE, Inc.
Investor Contacts: Lynn Lewis or Carrie
Mendivilinvestors@SI-BONE.com415-937-5405
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jun 2024 to Jul 2024
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jul 2023 to Jul 2024